Results
14
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
14 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
540737 | ₹794.55 | -5.9% | 15.1% | ₹10.2b | n/a | PE35.9x | n/a | 0% | ||
SATKARTAR | ₹219.00 | 45.0% | n/a | ₹3.4b | n/a | PE54.7x | n/a | n/a | ||
500420 | ₹3,259.40 | 0.006% | 22.7% | ₹1.1t | ₹3,639.83 | PE59.2x | E23.3% | 0.9% | ||
NATCOPHARM | ₹1,319.40 | 12.4% | 57.1% | ₹236.3b | ₹1,349.17 | PE12.2x | E-19.1% | 0.4% | ||
JAGSNPHARM | ₹266.65 | 6.8% | 112.5% | ₹17.7b | n/a | PE33.8x | n/a | 0.7% | ||
524632 | ₹219.65 | -4.0% | 471.6% | ₹9.6b | n/a | PE66.6x | n/a | 0.5% | ||
NIRMAN New | ₹344.45 | -2.7% | 24.7% | ₹2.1b | n/a | PE9.5x | n/a | 0.6% | ||
JSLL | ₹1,944.00 | 6.5% | 132.2% | ₹48.3b | n/a | PE57.4x | n/a | 0.2% | ||
INDSWFTLAB | ₹103.10 | -8.2% | -7.0% | ₹6.1b | n/a | PE1.6x | n/a | n/a | ||
524212 | ₹242.35 | 12.0% | 50.5% | ₹7.9b | n/a | PE15x | n/a | n/a | ||
500488 | ₹29,796.40 | 14.0% | 6.1% | ₹633.2b | ₹29,838.57 | PE47.4x | E11.2% | 1.4% | ||
539561 | ₹4.01 | -10.9% | -82.5% | ₹1.6b | n/a | PE6.7x | n/a | n/a | ||
531569 | ₹310.15 | -7.0% | 87.1% | ₹3.7b | n/a | PE53.3x | n/a | n/a | ||
BETA | ₹1,876.60 | -0.4% | 35.4% | ₹18.0b | n/a | PE44x | n/a | n/a |